Position in GILD
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$37,396
-$3,718 QoQ
Shares Held
296
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,087
of 2,266 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DHJJ Financial Advisors, Ltd. holds $2,259,093 across 11 Drug Manufacturers - General names. GILD ranks #9 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
4,522 | $581,077 | |
| 2 | JNJ |
Johnson & Johnson
|
2,058 | $522,670 | |
| 3 | LLY |
ELI LILLY & Co
|
348 | $417,401 | |
| 4 | ABBV |
AbbVie Inc.
|
1,638 | $412,186 | |
| 5 | AMGN |
Amgen Inc
|
319 | $115,516 | |
| 6 | AZN |
Astrazeneca PLC
|
400 | $75,848 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
825 | $47,536 | |
| 8 | PFE |
Pfizer Inc
|
1,744 | $41,995 |
All Filings in GILD
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,396 | 296 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $41,114 | 295 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $36,208 | 295 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $32,745 | 295 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $30,710 | 277 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $24,987 | 223 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $20,598 | 223 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $18,696 | 223 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $15,300 | 223 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $16,334 | 223 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $18,065 | 223 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $16,711 | 223 | Shares | Sole | 2023-10-10 | |
| No filing history on record for this holder in this stock. | ||||||